Literature DB >> 16938874

Fluorogenic metabolic probes for direct activity readout of redox enzymes: Selective measurement of human AKR1C2 in living cells.

Dominic J Yee1, Vojtech Balsanek, David R Bauman, Trevor M Penning, Dalibor Sames.   

Abstract

The current arsenal of tools and methods for the continuous monitoring and imaging of redox metabolic pathways in the context of intact cells is limited. Fluorogenic substrates allow for direct measurement of enzyme activity in situ; however, in contrast to proteases and exo-glycosidases, there are no simple guidelines for the design of selective probes for redox metabolic enzymes. Here, we introduce redox probe 1 and demonstrate its high selectivity in living cells for human hydroxysteroid dehydrogenases (HSDs) of the aldo-keto reductase (AKR) superfamily. AKR1C isoforms perform multiple functions among which the metabolism of potent steroid hormones is well documented. Moreover, expression of these enzymes is responsive to cellular stress and pathogenesis, including cancer. Our probe design is based on redox-sensitive optical switches, which couple a ketone-alcohol redox event to a profound change in fluorescence. The high selectivity of phenyl ketone 1 for AKR1C2 over the many endogenous reductases present in mammalian cells was established by a quantitative comparison of the metabolic rates between null control cells (COS-1) and AKR1C2-transfected cells. Phenyl ketone 1 is a cell-permeable fluorogenic probe that permits a direct, real-time, and operationally simple readout of AKR1C2 enzyme activity in intact mammalian cells. Furthermore, it was demonstrated that probe 1 enables the quantitative examination of physiological substrate 5alpha-dihydrotestosterone ("dark substrate") in situ by means of a two-substrate competitive assay. Similarly, inhibitor potency of physiological (ursodeoxycholate) and synthetic inhibitors (flufenamic acid, ibuprofen, and naproxen) was also readily evaluated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938874      PMCID: PMC1569159          DOI: 10.1073/pnas.0604672103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Real-time measurements of dark substrate catalysis.

Authors:  D Xie; L Suvorov; J W Erickson; A S Gulnik
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 2.  Enzyme cytochemical techniques for metabolic mapping in living cells, with special reference to proteolysis.

Authors:  E Boonacker; C J Van Noorden
Journal:  J Histochem Cytochem       Date:  2001-12       Impact factor: 2.479

3.  Design and synthesis of a fluorescent reporter of protein kinase activity.

Authors:  Chien-An Chen; Ren-Hwa Yeh; David S Lawrence
Journal:  J Am Chem Soc       Date:  2002-04-17       Impact factor: 15.419

4.  Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.

Authors:  T M Penning; M E Burczynski; J M Jez; C F Hung; H K Lin; H Ma; M Moore; N Palackal; K Ratnam
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

5.  Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).

Authors:  John W Trauger; Alice Jiang; Brian A Stearns; Philip V LoGrasso
Journal:  Biochemistry       Date:  2002-11-12       Impact factor: 3.162

6.  Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines.

Authors:  Noriyuki Usami; Tomohiro Yamamoto; Syunichi Shintani; Shuhei Ishikura; Yu Higaki; Yoshihiro Katagiri; Akira Hara
Journal:  Biol Pharm Bull       Date:  2002-04       Impact factor: 2.233

7.  Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells.

Authors:  Tea Lanisnik Rizner; Hsueh K Lin; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2003-02-01       Impact factor: 5.192

Review 8.  The roles of aldo-keto reductases in steroid hormone action.

Authors:  David R Bauman; Stephan Steckelbroeck; Trevor M Penning
Journal:  Drug News Perspect       Date:  2004-11

9.  The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.

Authors:  Julian C Desmond; Joanne C Mountford; Mark T Drayson; Elizabeth A Walker; Martin Hewison; Jonathan P Ride; Quang T Luong; Rachel E Hayden; Elio F Vanin; Christopher M Bunce
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

10.  Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.

Authors:  Tea Lanisnik Rizner; Hsueh K Lin; Donna M Peehl; Stephan Steckelbroeck; David R Bauman; Trevor M Penning
Journal:  Endocrinology       Date:  2003-07       Impact factor: 4.736

View more
  8 in total

Review 1.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma.

Authors:  Maria R Abbattista; Stephen M F Jamieson; Yongchuan Gu; Jennifer E Nickel; Susan M Pullen; Adam V Patterson; William R Wilson; Christopher P Guise
Journal:  Cancer Biol Ther       Date:  2015-04-14       Impact factor: 4.742

3.  Functional dynamics of H3K9 methylation during meiotic prophase progression.

Authors:  Makoto Tachibana; Masami Nozaki; Naoki Takeda; Yoichi Shinkai
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

4.  Activatable Optical Probes for the Detection of Enzymes.

Authors:  Christopher R Drake; David C Miller; Ella F Jones
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

5.  Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction.

Authors:  Giada Ostinelli; Sofia Laforest; Scott G Denham; Marie-Frederique Gauthier; Virginie Drolet-Labelle; Emma Scott; Frédéric-Simon Hould; Simon Marceau; Natalie Z M Homer; Catherine Bégin; Ruth Andrew; André Tchernof
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

6.  AKR1C enzymes sustain therapy resistance in paediatric T-ALL.

Authors:  Roberta Bortolozzi; Silvia Bresolin; Elena Rampazzo; Maddalena Paganin; Francesca Maule; Elena Mariotto; Daniele Boso; Sonia Minuzzo; Valentina Agnusdei; Giampietro Viola; Geertruy Te Kronnie; Giovanni Cazzaniga; Giuseppe Basso; Luca Persano
Journal:  Br J Cancer       Date:  2018-03-08       Impact factor: 7.640

7.  Dermacozine N, the First Natural Linear Pentacyclic Oxazinophenazine with UV-Vis Absorption Maxima in the Near Infrared Region, along with Dermacozines O and P Isolated from the Mariana Trench Sediment Strain Dermacoccus abyssi MT 1.1T.

Authors:  Bertalan Juhasz; Dawrin Pech-Puch; Jioji N Tabudravu; Bastien Cautain; Fernando Reyes; Carlos Jiménez; Kwaku Kyeremeh; Marcel Jaspars
Journal:  Mar Drugs       Date:  2021-06-03       Impact factor: 5.118

8.  Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A.

Authors:  Melanie M Erzinger; Cédric Bovet; Katrin M Hecht; Sabine Senger; Pascale Winiker; Nadine Sobotzki; Simona Cristea; Niko Beerenwinkel; Jerry W Shay; Giancarlo Marra; Bernd Wollscheid; Shana J Sturla
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.